Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Abstract Aim The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management
of Patients With Chronic Coronary Disease” provides an update to and consolidates new …

ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …

Aim The guideline for coronary artery revascularization replaces the 2011 coronary artery
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …

Preeclampsia is a hypertensive disorder of pregnancy. It affects 2% to 8% of pregnancies
worldwide and causes significant maternal and perinatal morbidity and mortality …

Menopause is often a turning point for women's health worldwide. Increasing knowledge
from experimental data and clinical studies indicates that cardiometabolic changes can …

As populations age worldwide, the burden of valvular heart disease has grown
exponentially, and so has the proportion of affected women. Although rheumatic valve …

Cardiovascular disease is the leading cause of death in women, yet differences exist among
certain racial and ethnic groups. Aside from traditional risk factors, behavioral and …

The United States has the highest maternal mortality rates among developed countries, and
cardiovascular disease is the leading cause. Therefore, the American Heart Association has …

Cardiovascular disease remains the leading cause of death in women. Given accumulating
evidence on sex-and gender-based differences in cardiovascular disease development and …